Загрузка...
Comment on Gomez et. al. “Response to article by Wasserman et. al. (2018) ‘Modelling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico’”
In a recent Letter, Gomez et. al. provided a critique of our original analysis estimating the clinical and economic impact of switching from the 13-valent (PCV13) to the 10-valent (PCV10) pneumococcal conjugate vaccine in Mexico. This comment addresses Gomez et. al.’s comments with additional inform...
Сохранить в:
| Опубликовано в: : | Hum Vaccin Immunother |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6988870/ https://ncbi.nlm.nih.gov/pubmed/30657407 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1558691 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|